Fibromyalgia: 黑料网
黑料网
Advances in Fibromyalgia Medication
Search results for
Advances in Fibromyalgia Medication
Our Group organises 3000+ Global Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ 黑料网 Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
黑料网 Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers
Indexed In
- RefSeek
- Hamdard University
- EBSCO A-Z
Useful Links
Share This Page
Advances in Fibromyalgia Medication
A new drug was Cymbalta (duloxetine), Savella (milnacipran) and Lyrica (pregabalin). Gamma Hydroxybutyrate was also introduced but it was later withdrawn by the FDA because of its high abuse potential.
Related journals of Advances in Fibromyalgia Medication
Fibromyalgia: 黑料网, Journal of Arthritis, International Journal of Physical Medicine & Rehabilitation, Rheumatology: Current Research, Journal of Sports Medicine & Doping Studies, International Journal of Ayurvedic and Herbal Medicine, Journal of Alternative and Complementary Medicine, Journal of Ayurveda and Integrative Medicine, International Journal of Ayurvedic Medicine, International Journal of Research in Ayurveda and Pharmacy.